Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin versus cetirizine for chronic urticaria
IRCT20171030037093N17Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in chronic idiopathic urticaria (CIU) comparing Atorvastatin arm with Cetirizine arm (2 arms). Primary endpoints: Clinical symptoms of hives, Slight clinical symptoms of hives and 2 more. Started Aug 2019; status: completed.
02
Drugs
atorvastatincetirizine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on IRCT20171030037093N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N17.